Fig. 2 | Scientific Reports

Fig. 2

From: Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation

Fig. 2

Identification of key NRDEGs to construct DCM disease-related progression and prognosis models. (A,B) Least absolute shrinkage and selection operator (LASSO) logistic regression algorithm to screen key genes. (C–E) Receiver operating characteristic (ROC) curves analysis of training set (C), testing set (D) and total dataset (E). AUC, area under the curve.

Back to article page